
Psychosomatics 49:218-224, May 2008
doi: 10.1176/appi.psy.49.3.218
© 2008 Academy of Psychosomatic Medicine
Depression After Diagnosis of Advanced Non-Small Cell Lung Cancer and Survival: A Pilot Study
William F. Pirl, M.D.,
Jennifer S. Temel, M.D.,
Andrew Billings, M.D.,
Constance Dahlin, APRN, B.C.,
Vicki Jackson,, M.D., M.P.H.,
Holly G. Prigerson, Ph.D.,
Joseph Greer, Ph.D., and
Thomas J. Lynch, M.D.
Received January 4, 2007; revised April 3, 2007; accepted April 18, 2007. From Massachusetts General Hospital Cancer Center, Boston, MA; Dana-Farber Cancer Institute, Boston, MA. Send correspondence and reprint requests to William F. Pirl, M.D., Massachusetts General Hospital, WACC 812, 15 Parkman St., Boston, MA 02114. e-mail: wpirl{at}partners.org
© 2008 The Academy of Psychosomatic Medicine
BACKGROUND: Major depressive disorder is estimated to occur in 10%–25% of people with cancer, and it has been inconsistently linked to increased mortality. OBJECTIVE: This pilot study investigates the association of depression and survival in advanced non-small cell lung cancer (NSCLC) patients. METHOD: Forty-three recently-diagnosed advanced NSCLC patients completed the Hospital Anxiety and Depression Scale and were followed prospectively. RESULTS: Patients with depression had poorer survival. Median survival was four times shorter than those without depression. Controlling for baseline performance status, depression predicted 6-month mortality, but was not significant for overall survival. CONCLUSION: Although depression after advanced-NSCLC diagnosis was associated with poorer survival at 6 months, this association was not present for overall survival; however, further research with larger samples should be pursued.
Key Words: Depression Lung Cancer Survival
Get information about faster international access.
a>
Privacy Policy
Copyright © 2008
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|